What a Normal Cholesterol Panel Misses — and Why It Matters

A significant portion of first heart attacks occur in people whose standard cholesterol panel was normal.

That statement tends to stop patients, because the standard lipid panel is the test most people equate with cardiac risk assessment. It’s what gets ordered at an annual physical, it’s what gets reviewed in a two-minute conversation, and a result inside the reference range is generally treated as an all-clear.

It isn’t one. The standard panel measures a limited set of variables, and several of the most predictive markers of cardiovascular risk simply aren’t on it.

At My Concierge MD in Beverly Hills, Dr. David Nazarian approaches cardiovascular risk assessment with the depth the question actually warrants — which means testing beyond the panel that has been standard since the 1970s.

What the Standard Panel Actually Tells You

A conventional lipid panel reports total cholesterol, LDL cholesterol, HDL cholesterol, and triglycerides.

LDL cholesterol — the number most patients focus on — measures the amount of cholesterol being carried by LDL particles. It’s a reasonable population-level risk indicator, and lowering it reduces risk.

What it doesn’t measure is how many particles are doing the carrying. And that distinction turns out to matter considerably.

ApoB: The Particle Count

Every atherogenic lipoprotein particle — LDL, VLDL, IDL, and Lp(a) — carries exactly one apolipoprotein B molecule. Measuring ApoB therefore gives a direct count of how many potentially artery-damaging particles are circulating.

Why that matters: arterial damage is driven by particles penetrating the arterial wall, not by the cholesterol volume they collectively contain. Two patients with identical LDL cholesterol can have substantially different particle counts. The patient carrying the same cholesterol in a larger number of smaller particles has more opportunities for arterial penetration — and meaningfully higher risk — despite an identical LDL number.

This pattern, sometimes called discordance, is common. It’s particularly common in patients with metabolic syndrome, insulin resistance, or elevated triglycerides — which describes a large share of the adult population.

ApoB is inexpensive, widely available, and a better predictor of cardiovascular events than LDL cholesterol. It is still not routinely ordered in most primary care settings.

Lp(a): The Genetic Risk Factor Most People Have Never Been Tested For

Lipoprotein(a) is an LDL-like particle with an additional protein attached. It’s both atherogenic and prothrombotic — it contributes to plaque formation and to clot formation.

Levels are roughly 90 percent genetically determined, established at birth, and largely unaffected by diet, exercise, or statin therapy. Approximately one in five people has an elevated level.

Elevated Lp(a) is an independent risk factor for heart attack, stroke, and aortic stenosis. It’s a meaningful part of the explanation for premature cardiac events in people with otherwise unremarkable risk profiles and no obvious lifestyle contributors.

Because it’s genetic and stable, it needs to be measured once in a lifetime. Most people never have been. For a patient with a family history of early cardiac disease, this single test frequently reframes the entire risk conversation — and it changes how aggressively other modifiable factors should be managed.

Coronary Artery Calcium Score: Looking Directly at the Arteries

Every blood marker is an inference about risk. A CAC score is a direct measurement of what’s actually present.

It’s a low-radiation CT scan that quantifies calcified plaque in the coronary arteries, producing a numerical score.

A score of zero in an asymptomatic patient indicates very low short-term event risk and is one of the most reassuring findings in preventive cardiology. An elevated score establishes that atherosclerosis is present — not theoretical, not projected from risk factors, but present and measurable.

This distinction has real clinical consequences. A patient with borderline lab values and a calcium score of zero occupies a very different position than a patient with identical labs and a score of 300. The first may reasonably continue monitoring. The second has documented disease requiring active management.

The test takes minutes, requires no contrast, and is relatively inexpensive.

Inflammatory and Metabolic Markers

• hs-CRP measures systemic inflammation. Atherosclerosis is fundamentally an inflammatory process, and elevated hs-CRP independently predicts cardiovascular events. It also identifies patients who derive particular benefit from certain interventions.
• Fasting insulin and HOMA-IR identify insulin resistance — which precedes type 2 diabetes by years or decades and independently drives cardiovascular risk. Fasting glucose and HbA1c often remain normal well into significant insulin resistance. Fasting insulin catches it substantially earlier, and that window is when intervention is most effective.
• Homocysteine, uric acid, and advanced lipoprotein fractionation add further resolution depending on the individual picture.

Why This Testing Isn’t Standard

This isn’t a failure of individual physicians. It’s a structural feature of how conventional primary care operates.

A fifteen-minute appointment covering multiple complaints, medication management, preventive screening, and documentation doesn’t accommodate a thorough cardiovascular risk conversation. Insurance reimbursement is built around treating established disease rather than detailed risk stratification in asymptomatic patients. Some of these tests require prior authorization or aren’t covered at all.

The result is that guideline-minimum care becomes the practical standard — and guideline minimums are written for population-level management, not for a specific patient who wants to know where they actually stand.

What Comprehensive Assessment Includes at My Concierge MD

Dr. Nazarian’s cardiovascular risk evaluation goes well beyond the standard panel: advanced lipid testing including ApoB and Lp(a), inflammatory markers, comprehensive metabolic and insulin assessment, blood pressure evaluation, and coordination for imaging including coronary calcium scoring where indicated.

Equally important is the time to interpret it. A patient with elevated ApoB, normal LDL, elevated Lp(a), and a calcium score of 90 has a specific, actionable situation — one that requires an actual conversation about what each finding means, how the pieces interact, and what the management plan should be.

That conversation is what the concierge model exists to make possible. Appointments aren’t fifteen minutes. Results aren’t delivered through a patient portal message. And the physician reviewing them knows the patient’s full history and goals.

Who Should Consider This

Anyone with a family history of premature cardiovascular disease. Anyone who has been told their cholesterol is “fine” but has other risk factors. Anyone with elevated blood pressure, prediabetes, or metabolic syndrome. Anyone over 40 who wants an accurate picture rather than a reassuring one. And anyone who has never had ApoB or Lp(a) measured — which is most people.

Schedule Your Consultation at My Concierge MD

Dr. David Nazarian and the My Concierge MD team are located at 9301 Wilshire Boulevard, Suite 405A, in Beverly Hills, serving patients throughout Los Angeles, Bel Air, Century City, West Hollywood, and Santa Monica.

Call (310) 299-8959 to schedule.

A normal cholesterol panel answers one question. It isn’t the only question worth asking.

This blog is educational. Cardiovascular risk assessment and treatment decisions should be made following a comprehensive evaluation with a qualified physician.

Medically reviewed by David Nazarian, MD on September 29, 2026